JK-05
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| CAS Number | |
JK-05 is a broad-spectrum
2014 West African Ebola outbreak, or if Ebola were to spread into mainland China.[3][1][4][5][6][7] Several other Chinese developed antiviral drugs with anti-Ebola activity have also been disclosed,[8] but have not progressed so far through development as JK-05.[citation needed
]
See also
References
- ^ a b Jourdan A (2014-10-14). "China military-linked firm eyes quick approval of drug to cure Ebola". Reuters.
- ^ "Suspected Pakuri in "Ebola special drug" developed in Japan WHO points out that the same ingredient is manufactured in China". J-CAST News (in Japanese). Archived from the original on 2014-11-29. Retrieved 2014-11-21.
- ^ Pinghui Z (1 September 2014). "Ebola virus drug approved on mainland for emergency use only". South China Morning Post.
- ^ Yang K. "China approves Ebola drug for emergency use". Bioworld.com.
- ^ "La Chine envoie des médicaments contre Ebola en Afrique". CRI Online (in French). 18 October 2014. Archived from the original on 3 March 2016. Retrieved 19 October 2014.
- ^ "Sihuan Pharma Company Update" (PDF). 15 October 2014.
- ^ Sieren F (23 October 2014). "Beijing develops Ebola drug". Deutsche Welle.
- PMID 25345954.